These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


178 related items for PubMed ID: 6432499

  • 1. Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.
    Wilson JA, Boyd EJ, Wormsley KG.
    Dig Dis Sci; 1984 Sep; 29(9):797-801. PubMed ID: 6432499
    [Abstract] [Full Text] [Related]

  • 2. Effects of single and repeated doses of omeprazole on gastric acid and pepsin secretion in man.
    Howden CW, Forrest JA, Reid JL.
    Gut; 1984 Jul; 25(7):707-10. PubMed ID: 6428981
    [Abstract] [Full Text] [Related]

  • 3. Effect of omeprazole on the secretion of intrinsic factor, gastric acid and pepsin in man.
    Kittang E, Aadland E, Schjønsby H.
    Gut; 1985 Jun; 26(6):594-8. PubMed ID: 3924748
    [Abstract] [Full Text] [Related]

  • 4. Effect of omeprazole on gastric acid secretion in man.
    Olbe L, Lind T, Cederberg C, Ekenved G.
    Scand J Gastroenterol Suppl; 1986 Jun; 118():105-7. PubMed ID: 3460164
    [Abstract] [Full Text] [Related]

  • 5. Basal, sham feed and pentagastrin stimulated gastric acid, pepsin and electrolytes after omeprazole 20 mg and 40 mg daily.
    Thompson JN, Barr JA, Collier N, Spencer J, Bush A, Cope L, Gribble RJ, Baron JH.
    Gut; 1985 Oct; 26(10):1018-24. PubMed ID: 3932137
    [Abstract] [Full Text] [Related]

  • 6. Effect of omeprazole--a gastric proton pump inhibitor--on pentagastrin stimulated acid secretion in man.
    Lind T, Cederberg C, Ekenved G, Haglund U, Olbe L.
    Gut; 1983 Apr; 24(4):270-6. PubMed ID: 6832622
    [Abstract] [Full Text] [Related]

  • 7. Acid inhibitory characteristics of omeprazole in man.
    Cederberg C, Ekenved G, Lind T, Olbe L.
    Scand J Gastroenterol Suppl; 1985 Apr; 108():105-12. PubMed ID: 3858972
    [Abstract] [Full Text] [Related]

  • 8. Effect of single and repeated doses of oral omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels.
    Festen HP, Tuynman HA, Défize J, Pals G, Frants RR, Straub JP, Meuwissen SG.
    Dig Dis Sci; 1986 Jun; 31(6):561-6. PubMed ID: 3086061
    [Abstract] [Full Text] [Related]

  • 9. [Suppression of acid secretion and plasma level of a once-daily dose of omeprazole].
    Müller P, Seitz HK, Simon B, Dammann HG.
    Arzneimittelforschung; 1983 Jun; 33(12):1685-6. PubMed ID: 6686775
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of pentagastrin-stimulated and overnight gastric secretion by LM24056, a new phenothiazine-derived antisecretory drug.
    Boyd EJ, Wormsley KG.
    Lancet; 1981 Feb 28; 1(8218):471-3. PubMed ID: 6110093
    [Abstract] [Full Text] [Related]

  • 11. Influence of the stimulation state of the parietal cells on the inhibitory effect of omeprazole on gastric acid secretion in dogs.
    De Graef J, Woussen-Colle MC.
    Gastroenterology; 1986 Aug 28; 91(2):333-7. PubMed ID: 2873074
    [Abstract] [Full Text] [Related]

  • 12. Effect of high dose omeprazole on gastric pepsin secretion and serum pepsinogen levels in man.
    Ten Kate RW, Tuynman HA, Festen HP, Pals G, Meuwissen SG.
    Eur J Clin Pharmacol; 1988 Aug 28; 35(2):173-6. PubMed ID: 3142776
    [Abstract] [Full Text] [Related]

  • 13. Initial potency of lansoprazole and omeprazole tablets on pentagastrin-stimulated gastric acid secretion-a placebo-controlled study in healthy volunteers.
    Müller P, Göksu MA, Fuchs W, Schlüter F, Simon B.
    Aliment Pharmacol Ther; 2000 Sep 28; 14(9):1225-9. PubMed ID: 10971240
    [Abstract] [Full Text] [Related]

  • 14. Antisecretory effect and oral pharmacokinetics following low dose omeprazole in man.
    Howden CW, Forrest JA, Meredith PA, Reid JL.
    Br J Clin Pharmacol; 1985 Aug 28; 20(2):137-9. PubMed ID: 3929808
    [Abstract] [Full Text] [Related]

  • 15. [Behavior of acid secretion under the long-term daily administration of omeprazol].
    Dammann HG, Müller P, Seitz HK, Simon B.
    Schweiz Med Wochenschr; 1983 Jun 18; 113(24):895-8. PubMed ID: 6348940
    [Abstract] [Full Text] [Related]

  • 16. Omeprazole, a long-lasting inhibitor of gastric secretion.
    Larson GM, Sullivan HW.
    J Surg Res; 1984 May 18; 36(5):503-7. PubMed ID: 6727328
    [Abstract] [Full Text] [Related]

  • 17. Effects of rioprostil on gastric acid and pepsin secretion in man: a review of studies in healthy volunteers.
    Demol P, Singer MV, Dammann HG, Richardson CT, Weihrauch TR.
    Scand J Gastroenterol Suppl; 1989 May 18; 164():74-9; discussion 79-80. PubMed ID: 2510285
    [Abstract] [Full Text] [Related]

  • 18. Stimulated pepsin secretion after omeprazole-induced acid suppression in the totally isolated, vascularly perfused rat stomach.
    Sandvik AK, Kleveland PM, Waldum HL.
    Scand J Gastroenterol; 1987 Apr 18; 22(3):362-6. PubMed ID: 2438747
    [Abstract] [Full Text] [Related]

  • 19. Omeprazole inhibition of nocturnal gastric secretion in patients with duodenal ulcer.
    Hetzel DJ, Shearman DJ.
    Br J Clin Pharmacol; 1984 Oct 18; 18(4):587-90. PubMed ID: 6487498
    [Abstract] [Full Text] [Related]

  • 20. Inhibition of pentagastrin-stimulated gastric acid secretion by pantoprazole and omeprazole in healthy adults.
    Pratha VS, Hogan DL, Lane JR, Williams PJ, Burton MS, Lynn RB, Karlstadt RG.
    Dig Dis Sci; 2006 Jan 18; 51(1):123-31. PubMed ID: 16416224
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.